A forskolin-mediated increase in cAMP promotes T helper cell differentiation into the Th1 and Th2 subsets rather than into the Th17 subset
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
37948861
DOI
10.1016/j.intimp.2023.111166
PII: S1567-5769(23)01492-3
Knihovny.cz E-resources
- MeSH
- Lymphocyte Activation * MeSH
- Cyclic AMP * MeSH
- Cell Differentiation MeSH
- Th17 Cells MeSH
- Colforsin pharmacology MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Cyclic AMP * MeSH
- Colforsin MeSH
The adenylyl cyclase (AC) signaling pathway is suggested to be a key regulator of immune system functions. However, specific effects of cyclic adenosine monophosphate (cAMP) on T helper (Th) cell differentiation and functions are unclear. The involvement of cAMP in the Th cell differentiation program, in particular the development of Th1, Th2, and Th17 subsets, was evaluated employing forskolin (FSK), a labdane diterpene well known as an AC activator. FSK mediated an elevation in Th1-specific markers reinforcing the Th1 cell phenotype. The Th2 differentiation was supported by FSK, though cell metabolism was negatively affected. In contrast, the Th17 immunophenotype was severely suppressed leading to the highly specific upregulation of CXCL13. The causality between FSK-elicited cAMP production and the observed reinforcement of Th2 differentiation was established by using AC inhibitor 2',5'-dideoxyadenosine, which reverted the FSK effects. Overall, an FSK-mediated cAMP increase affects Th1, Th2 and Th17 differentiation and can contribute to the identification of novel therapeutic targets for the treatment of Th cell-related pathological processes.
References provided by Crossref.org